Agios Pharmaceuticals, Inc.

Ownership Transactions Reported by 24 Insiders

Symbol
AGIO on Nasdaq
Industry
Pharmaceutical Preparations
Location
88 Sidney Street, Cambridge, Massachusetts

Insiders trading volume in the past year

Agios Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
David Schenkein Director $10.1M -$4.66M -31.5% Jun 20, 2024
Brian Goff Chief Executive Officer, Director $7.76M -$1.64M -17.5% Aug 8, 2024
Jacqualyn Fouse Director $6.98M -$640K -8.39% Jun 20, 2024
Sarah Gheuens Chief Medical Officer $2.74M -$343K -11.1% Jul 1, 2024
James Burns Chief Legal Officer $1.49M -$163K -9.89% Mar 1, 2024
Tsveta Milanova Chief Commercial Officer $880K -$99.8K -10.2% Mar 1, 2024
David Scadden Director $860K Jun 20, 2024
Maykin Ho Director $832K Jun 20, 2024
John Maraganore Director $617K Dec 31, 2022
Cecilia Jones Chief Financial Officer $614K -$117K -16% Mar 1, 2024
Kaye I. Foster-Cheek Director $472K -$192K -28.9% Jun 20, 2024
Rahul Ballal Director $440K Aug 11, 2024
Cynthia Smith Director $440K Aug 11, 2024
Christopher Bowden Chief Medical Officer $335K Jun 18, 2021
Bruce Car Chief Scientific Officer $285K Mar 1, 2022
Jonathan Biller Chief Financial Officer $285K Mar 1, 2022
Theodore James Jr. Washburn Principal Accounting Officer $221K -$181K -45.1% Jun 3, 2024
Jeffrey Capello Director $200K Jun 20, 2024
E. Owen Director $200K Jun 20, 2024
Richa Poddar Chief Commercial Officer $184K Oct 15, 2022
Darrin Miles Chief Commercial Officer $156K May 14, 2021
Ian T. Clark Director $142K May 20, 2022
Paul J. Clancy Director $123K Jun 21, 2022
Carman Alenson Principal Accounting Officer Jun 21, 2021

Recent Insider Transactions by Companies or Individuals for Agios Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.